Restart Life Sciences Financial Overview
Restart Life Sciences's market cap is currently C$4.02M. The company's EPS TTM is C$-0.006; its P/E ratio is -2.58; Restart Life Sciences is scheduled to report earnings on November 26, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
